JPAC Joint United Kingdom (UK) Blood Transfusion and Tissue Transplantation Services Professional Advisory Committee

Prion Associated Diseases

Including

Familial, sporadic and variant Creutzfeldt-Jacob disease (CJD), Gerstmann-Strãussler-Scheinker disease and fatal familial insomnia.

Obligatory

Must not donate if:
1.
Diagnosed with any form of CJD, or other human prion disease.

2. Identified at increased risk of developing a prion associated disorder.
This includes:
a) Individuals at familial risk of prion-associated diseases (have had two or more blood relatives develop a prion-associated disease or have been informed following genetic counselling they are at risk).

b) Individuals who have been told that they have been put at increased risk from surgery, transfusion or transplant of tissues or organs.

c) Individuals who have been told that they may be at increased risk because a recipient of their blood or tissues has developed a prion related disorder.

d) Recipients of dura mater grafts.

e) Recipients of corneal, scleral or other ocular tissue grafts.

f) Recipients of human pituitary derived extracts.

g) Since January 1st 1980:
Recipients of a transfusion or allogeneic human tissue.

Discretionary

If the donor has had two or more blood relatives develop a prion-associated disease and, following genetic counselling, they have been informed that they are not at risk, accept.
This requires confirmation by a 'Designated Clinical Support Officer'.

See if Relevant

Tissue and Organ Recipients
Transfusion

Additional Information

A 'Position Statement on Creutzfeldt-Jakob Disease' is available in the 'Document Library' of 'www.transfusionguidelines.org'.

The use of human gonadotrophin and growth hormone of pituitary origin had stopped in the UK by 1986. Dura mater use stopped in the UK by 1993. The situation in other countries varied so specific dates cannot be given.

Information

Part of this entry is a requirement of the Blood Safety and Quality Regulations 2005.

It also Includes Department of Health decisions about individuals who have been identified at an increased risk of developing a prion related disease.

Reason for change

Relevant links have been added.

'Additional Information' on the use of dura mater and human hormones of pituitary origin has been added.

Donor Information

If you wish to obtain more information regarding a personal medical issue please contact your National Help Line.

Please do not contact this web site for personal medical queries, as we are not in a position to provide individual answers.

Update Information

This entry was last updated in:
DSG-WB Edition 203, Release 01.